Study on Urinary Metabolomics of Premenstrual Dysphoric Disorder Patients with Liver-Qi Depression Syndrome Treated With Xiaoyao Powder
- Conditions
- Premenstrual Dysphoric Disorder
- Registration Number
- ITMCTR1900002634
- Lead Sponsor
- Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
1. It conforms to the diagnostic criteria of PMDD in the 5th edition of the Manual of Diagnosis and Statistics of Mental Diseases (DSM-5), and the diagnosis of TCM syndromes conforms to the syndrome of Liver-qi depression.
2. Women aged between 18 and 30 are of unlimited ethnic origin.
3. The basic regularity of menstrual cycle (fluctuation range < 3d) is 21-35 days.
4. Clear-minded and independent judgement; able to understand the purpose of this study and cooperate voluntarily.
5. No major diseases, no heart, liver and kidney tumors, brain tumors or other brain diseases, no history of taking psychotropic drugs.
1. Drugs for PMDD were used within three months.
2. History of drug abuse.
3. Those who participated in other drug clinical trials within one month before screening.
4. Diseases of the blood system.
5. Pregnant or lactating women.
6. Chronic history of five visceral diseases such as heart and spleen.
7. Ovariectomy or abortion within six months, contraceptive use.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine metabonomics;
- Secondary Outcome Measures
Name Time Method